Our Company
Our Mission & Commitment
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Investigational Compound News
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Investigator- Sponsored Research
Products
Help Paying For Your Medicine
Counterfeit Drugs
Medical Information Inquiries
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Help Paying For Your Medicine
Building Our Communities
Grants & Giving
Position on Key Issues
Transparency
Clinical Trials
Combating Counterfeit Drugs
Disaster Relief & Product Donations
Achievements
Access to Medicines
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Apply Now
SITE INDEX
|
CONTACT US
|
TERMS
|
PRIVACY
Clinical Trials and Research
Learn about Bristol-Myers Squibb's
Clinical Trial Activities
and
Investigator-Sponsored Research
Need Help Paying for Your
Bristol-Myers Squibb Medicines?
Learn about our
assistance programs
.
Patients and
Caregivers
Learn about clinical trial participation at
Bristol-Myers Squibb
Study Connect
Health Care Professionals
Access
medical information and resources
California Transparency in Supply Chains (PDF)
Our Environmental Stewardship
Bristol-Myers Squibb Delivers Solid Fourth Quarter Results
Year highlighted by new product approvals, continued focus on strategic transactions and good operating performance
LATEST NEWS
January 26, 2012
Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance
January 24, 2012
Bristol-Myers Squibb Names Gerald L. Storch to Board of Directors
January 19, 2012
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients
January 19, 2012
Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin
Get RSS News Alerts
Follow us on twitter.com/bmsnews